advertisement
Kamalipour A 24
Showing records 1 to 24 | Display all abstracts from Kamalipour A109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Wu JH
Journal of Glaucoma 2023; 32: 549-555
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Moghimi S
American Journal of Ophthalmology 2023; 252: 295-305
110111 Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes
Salabati M; Huang C
Ophthalmology science 2024; 4: 100372
109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Moghimi S
Journal of Glaucoma 2023; 32: 549-555
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Kamalipour A
American Journal of Ophthalmology 2023; 252: 295-305
110111 Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes
Kamalipour A
Ophthalmology science 2024; 4: 100372
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Nishida T
American Journal of Ophthalmology 2023; 252: 295-305
109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Nishida T
Journal of Glaucoma 2023; 32: 549-555
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Zangwill L
American Journal of Ophthalmology 2023; 252: 295-305
109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Kamalipour A
Journal of Glaucoma 2023; 32: 549-555
110111 Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes
Yu HJ
Ophthalmology science 2024; 4: 100372
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Fazio M
American Journal of Ophthalmology 2023; 252: 295-305
110111 Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes
Mahmoudzadeh R
Ophthalmology science 2024; 4: 100372
109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Liebmann JM; Fazio M
Journal of Glaucoma 2023; 32: 549-555
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Girkin CA
American Journal of Ophthalmology 2023; 252: 295-305
110111 Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes
Jeng-Miller K
Ophthalmology science 2024; 4: 100372
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Liebmann JM
American Journal of Ophthalmology 2023; 252: 295-305
109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Girkin CA
Journal of Glaucoma 2023; 32: 549-555
110111 Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes
Chen E
Ophthalmology science 2024; 4: 100372
109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Zangwill LM
Journal of Glaucoma 2023; 32: 549-555
109221 Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma
Weinreb RN
American Journal of Ophthalmology 2023; 252: 295-305
110111 Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes
Shah CP; Wykoff CC
Ophthalmology science 2024; 4: 100372
109264 Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma
Weinreb RN
Journal of Glaucoma 2023; 32: 549-555
110111 Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes
Hsu J
Ophthalmology science 2024; 4: 100372